Quidel | سود ناخالص در فروش



Gross Profit On Sales تغییر دادن تاریخ
Abbott USD 6.03B 93M 2024-12
Agilent USD 899M 18M 2025-01
Avanos Medical USD 98M 5.1M 2024-12
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Bruker USD 493.3M 74.5M 2024-12
Charles River Laboratories USD 319.68M 48.09M 2024-12
Danaher USD 3.89B 489M 2024-12
Exact Sciences USD 429.29M 83.29M 2024-12
Haemonetics USD 196.57M 5.37M 2024-12
Hologic USD 580.5M 22.8M 2024-12
Illumina USD 728M 17M 2024-12
IQVIA Holdings USD 1.38B 0 2024-12
Merit Medical Systems USD 172.98M 15.45M 2024-12
Mettler Toledo International USD 639.31M 66.85M 2024-12
Myriad Genetics USD 150.9M 1.1M 2024-12
Neogen USD 110.26M 3.06M 2025-02
Quidel USD 326.1M 26.2M 2024-12
Revvity USD 412.29M 27.47M 2024-12
STAAR Surgical USD 31.65M 36.84M 2024-12
Thermo Fisher Scientific USD 4.82B 494M 2024-12
Waters USD 524.2M 85.55M 2024-12



Quidel سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Apr 2025.